Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.
Sarcura has raised $7.3M in total funding. The most recent round was Seed. The last funding was announced in November 2022.
Sarcura's investors include Nina Capital, HCVC, XISTA Science Ventures, NovaCapital, tecnet equity.
Sarcura is headquartered in Klosterneuburg, Austria.
Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.
Sarcura is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sarcura — Funding & Investors." VCBacked, November 17, 2022, https://www.vcbacked.co/company/sarcura. Accessed August 17, 2026.
VCBacked. (2022). Sarcura — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/sarcura
{{cite web |title=Sarcura — Funding & Investors |url=https://www.vcbacked.co/company/sarcura |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated